France· FR:67025669
PENTOXYVERINE CLARIX 0,15 % ADULTES, sirop
A pentoxyverine product containing citrate de pentoxyvérine, registered in France by COOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE). The same ATC class is registered in 6 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Pentoxyverine is registered in 6 of 19 countries.
Countries holding a registration under ATC R05DB05 (pentoxyverine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 4 of them publish a price we can compare per daily dose
Pentoxyverine · ATC R05DB05
6 / 19 countries
- Belgiumprice
- Finlandprice
- Franceprice
- Germany
- Japan
- Switzerlandprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CITRATE DE PENTOXYVÉRINE
- Manufacturer
- COOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- Country
- France (FR)
- ATC code
- R05DB05
- ATC class
- Pentoxyverine
- Defined daily dose
- 0.1 g, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009318316551 flacon(s) en verre jaune de 200 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
260 interactions on record for pentoxyverine.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pentoxyverine · interactions on record
260 records
- 7 severe
- 253 moderate
Most severe, free to view
- ProcarbazineL01XB01severe
- SelegilineN04BD01severe
- RasagilineN04BD02severe
- SafinamideN04BD03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pentoxyverine in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandBiseltocOpella Healthcare France SAS
- GermanyPentoxyverin AlAliud Pharma Gmbh
- BelgiumBalsoclase Antitussivum 2.13 mg/mlPierre Fabre Médicament
- SwedenBiseltoc 2,13 mg/ml Oral lösningOpella Healthcare France SAS
- SpainBISOLVON CALMATOS 2,13 MG/ML SOLUCION ORALOpella Healthcare Spain S.L.
- SwitzerlandBisolvon Pentoxyverin 2.13 mg/ml, SirupOpella Healthcare Switzerland AG
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Mucomat Hustenstiller
- Belgium · Pentoxyverine Sanofi, Pentoxyvérine Sanofi
- Germany · Pentoxyverin Al, Sedotussin Hustenstiller
- Spain · Bisolvon Calmatos
- Finland · Biseltoc
- Italy · Pentοssiverina Opella Healthcare
- Luxembourg · Pentoxyvérine Sanofi
- Norway · Biseltoc
- Portugal · Bisoltussin
- Sweden · Biseltoc
- Slovakia · Stadatussin, Stadatussin Kvapky
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f587c6b5-aadf-499a-895f-be3237df9a61 GET /v1/drugs/f587c6b5-aadf-499a-895f-be3237df9a61?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67025669",
"date_amm": "1996-05-06",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CITRATE DE PENTOXYVÉRINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "sirop",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about pentoxyverine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.